Program Track: Treatment of Inflammatory Periodontal Diseases
Moderator: Susan Karabin
Speakers: Georgia K. Johnson, Angelo Mariotti, David W. Paquette
Inflammatory periodontal disease usually requires life-long management, and often includes non-surgical, surgical, pharmacological and host modulation intervention. These therapies may have varying outcomes depending on the patient’s medical status, medications and lifestyle risk factors. The presenters will give an in-depth review of the current evidence related to obesity/diabetes, smoking cessation and bisphosphonates/osteonecrosis of the jaw (ONJ) as it relates to patients’ care and management.
Understand the impact of smoking on periodontal and implant therapy, and the benefits of smoking cessation.
Learn the association of bisphosonates with ONJ, as well as prevention and management of it.
Discuss the relationship between obesity, diabetes and periodontal disease, and how to manage patients who are at increased risk.